Douglas Taylor, PhD, MSDirector, Biostatistics
Areas of expertise
- Clinical trials
- Experimental design
- Statistical analysis
Projects & Resources
The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need.
The FEM-PrEP clinical trial was designed to assess whether a daily dose of the antiretroviral Truvada® is safe and effective at preventing HIV infection among women at high risk of HIV exposure.
The primary results of a trial of once-daily oral Truvada for pre-exposure prophylaxis for HIV infection among women in Africa (FEM-PrEP) are presented in an article published in The New England Journal of Medicine.